Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Brown, R, McNeillis, B, Goh, Y, Mutch, K, Jacob, S, Leite, M, Robertson, N, Palace, J, Jacob, A

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Brown, R, McNeillis, B, Goh, Y, Mutch, K, Jacob, S, Leite, M, Robertson, N, Palace, J, Jacob, A

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK. by Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Mutch, K, Jacob, S, Brown, R, Moss, K, McNeillis, B, Goh, Y, Leite, M, Robertson, N, Palace, J, Jacob, A

“…BACKGROUND: Azathioprine (AZA) is a common immunosuppressive drug used for relapse prevention in neuromyelitis optica (NMO). …”

Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two. by Schoser, B, Jacob, S, Hilton-Jones, D, Müller-Felber, W, Kubisch, C, Claus, D, Goebel, H, Vita, G, Vincent, A, Toscano, A, Van den Bergh, P

“…Generalized MG and iRMD were successfully treated with plasma exchange, steroids and azathioprine in the two patients followed long-term. …”